Glioma is the most common intracranial tumor, accounting for about half of intracranial tumors, the first symptoms vary according to the site, since glioma is recognized, the vast majority of neurosurgeons are committed to the study of glioma, the progress is obvious, however, the therapeutic effect has been unsatisfactory, the therapeutic effect on the one hand, determined by the pathology of the tumor and the individual factors, on the other hand, depends on whether the treatment is standardized and the treatment of various On the other hand, it depends on the standardization of the treatment and the degree to which the various steps in the treatment process are in place (which is what doctors can do). At present, the treatment of glioma has some standardization, surgery + radiotherapy + chemotherapy. There are some differences in the treatment options for different grades of tumors, but surgery is the preferred treatment option, and the surgical tumor resection rate is directly related to the patient’s survival. However, glioma surgery is relatively easy to perform among intracranial tumors, so hospitals at all levels are carrying out glioma surgery for various reasons, which results in differences in postoperative patient outcomes, and often the initial surgery is the most important factor in determining long-term outcomes. Surgery for gliomas requires a strong knowledge of neuroanatomy, neuropathology, and neuropathophysiology, as well as the surgeon’s experience and understanding of the abnormal anatomical structures in the presence of tumors. Therefore, glioma surgery is both simple and very difficult. Simple is that anyone can do it (with different degrees of tumor resection), but difficult is to do it well, not only to achieve maximum tumor resection but also to protect neurological function, so as to ensure the quality of patient’s survival and to improve the patient’s survival period.